-transparent.png){kind=logo}
The antihypertensive efficacy of once-daily amlodipine was studied in a group of 30 patients with mild to moderate hypertension in a double-blind, placebo-controlled, parallel-group study. The dose range of amlodipine was 2.5-10.0 mg daily adjusted every 2 weeks for a total treatment period of 8 weeks. Amlodipine produced a significant reduction in blood pressure compared with placebo, the mean difference between baseline and 8 weeks (corrected for placebo effect) being 16/12 mm Hg supine, 14/4 mm Hg standing. Blood pressure returned to baseline values during a terminal 4-week washout period with placebo. There were no significant effects on heart rate. Two patients experienced slight ankle edema while receiving amlodipine 10.0 mg daily but the active drug was otherwise well tolerated.
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
January 2003,
Current medical research and opinion,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
December 1992,
The Medical journal of Malaysia,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
January 1990,
Clinical therapeutics,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
June 1977,
British journal of clinical pharmacology,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
October 1983,
Singapore medical journal,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
August 1998,
European journal of pediatrics,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
January 1994,
Indian heart journal,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
November 1978,
European journal of clinical pharmacology,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
June 1994,
The American journal of cardiology,
J Webster, and
O J Robb, and
T A Jeffers, and
A K Scott, and
J C Petrie
December 1988,
The Journal of the American Osteopathic Association,
